Effect of dosing cycles on safety of denileukin diftitox (Dd) in cutaneous T-cell lymphoma (CTCL) patients: Integrated analysis of three phase III studies No significant financial relationships to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results